PHAGERIARUS Trademark

Trademark Overview


On Friday, April 23, 2021, a trademark application was filed for PHAGERIARUS with the United States Patent and Trademark Office. The USPTO has given the PHAGERIARUS trademark a serial number of 90667892. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by iNtRON Biotechnology, Inc.. The PHAGERIARUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products
phageriarus

General Information


Serial Number90667892
Word MarkPHAGERIARUS
Filing DateFriday, April 23, 2021
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7172143
Registration DateTuesday, September 26, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Goods and ServicesResearch and development relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceutical, biotech and vaccine sectors; research and development of pharmaceutical, biotech and vaccine products; consultancy relating to pharmaceutical, biotech and vaccine sectors; advisory services relating to research and development of pharmaceutical, biotech and vaccine products

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 30, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameiNtRON Biotechnology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSungnam-si,Kyeonggi-do 462-120
KR

Party NameiNtRON Biotechnology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSungnam-si,Kyeonggi-do 462-120
KR

Party NameiNtRON Biotechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSungnam-si,Kyeonggi-do 462-120
KR

Trademark Events


Event DateEvent Description
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, July 21, 2023NOTICE OF ALLOWANCE CANCELLED
Tuesday, August 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 21, 2023TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, July 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 13, 2023ASSIGNED TO LIE
Wednesday, January 18, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 4, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 4, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, August 4, 2022SUSPENSION INQUIRY WRITTEN
Friday, July 8, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, December 21, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 21, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, December 21, 2021SUSPENSION LETTER WRITTEN
Friday, December 17, 2021ASSIGNED TO EXAMINER
Friday, July 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 27, 2021NEW APPLICATION ENTERED